Advertisement
Loading...

Viatris Inc.

VTRSNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$16.48
$-0.78(-4.52%)
U.S. Market opens in 28h 22m

Viatris Inc. Fundamental Analysis

Viatris Inc. (VTRS) shows weak financial fundamentals with a PE ratio of -64.21, profit margin of -2.04%, and ROE of -1.97%. The company generates $14.7B in annual revenue with weak year-over-year growth of -2.98%.

Key Strengths

PEG Ratio-0.63
Current Ratio1.60

Areas of Concern

ROE-1.97%
Operating Margin0.96%
We analyze VTRS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 14.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
14.0/100

We analyze VTRS's fundamental strength across five key dimensions:

Efficiency Score

Weak

VTRS struggles to generate sufficient returns from assets.

ROA > 10%
-0.80%

Valuation Score

Excellent

VTRS trades at attractive valuation levels.

PE < 25
-64.21
PEG Ratio < 2
-0.63

Growth Score

Weak

VTRS faces weak or negative growth trends.

Revenue Growth > 5%
-2.98%
EPS Growth > 10%
-4.66%

Financial Health Score

Excellent

VTRS maintains a strong and stable balance sheet.

Debt/Equity < 1
0.98
Current Ratio > 1
1.60

Profitability Score

Weak

VTRS struggles to sustain strong margins.

ROE > 15%
-197.15%
Net Margin ≥ 15%
-2.04%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is VTRS Expensive or Cheap?

P/E Ratio

VTRS trades at -64.21 times earnings. This suggests potential undervaluation.

-64.21

PEG Ratio

When adjusting for growth, VTRS's PEG of -0.63 indicates potential undervaluation.

-0.63

Price to Book

The market values Viatris Inc. at 1.30 times its book value. This may indicate undervaluation.

1.30

EV/EBITDA

Enterprise value stands at 3.52 times EBITDA. This is generally considered low.

3.52

How Well Does VTRS Make Money?

Net Profit Margin

For every $100 in sales, Viatris Inc. keeps $-2.04 as profit after all expenses.

-2.04%

Operating Margin

Core operations generate 0.96 in profit for every $100 in revenue, before interest and taxes.

0.96%

ROE

Management delivers $-1.97 in profit for every $100 of shareholder equity.

-1.97%

ROA

Viatris Inc. generates $-0.80 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.80%

Following the Money - Real Cash Generation

Operating Cash Flow

Viatris Inc. produces operating cash flow of $2.19B, showing steady but balanced cash generation.

$2.19B

Free Cash Flow

Viatris Inc. generates strong free cash flow of $1.72B, providing ample flexibility for dividends, buybacks, or growth.

$1.72B

FCF Per Share

Each share generates $1.48 in free cash annually.

$1.48

FCF Yield

VTRS converts 8.90% of its market value into free cash.

8.90%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-64.21

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.63

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.30

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.32

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.98

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.60

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.02

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

0.005

vs 25 benchmark

How VTRS Stacks Against Its Sector Peers

MetricVTRS ValueSector AveragePerformance
P/E Ratio-64.2128.62 Better (Cheaper)
ROE-1.97%783.00% Weak
Net Margin-2.04%-48181.00% (disorted) Weak
Debt/Equity0.980.39 Weak (High Leverage)
Current Ratio1.604.12 Neutral
ROA-0.80%-21914.00% (disorted) Weak

VTRS outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Viatris Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-38.53%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-169.45%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-3.45%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ